Guides

Anavar Dosage for Women: Safe Ranges, Cycle Length & Virilization Warning Signs

Woman athlete in a gym reviewing a weekly training planner with a pill organizer on the bench beside her

For women, the dose of Anavar (oxandrolone) most commonly discussed in training circles is 5–10 mg per day, split into two doses, for 4–6 weeks — starting at 5 mg and only moving to 10 mg after a full lower-dose cycle with no warning signs. That range is not a medical recommendation — the only approved label dose is 2.5–20 mg per day, and no dose is approved for physique or performance use. Women respond to far smaller amounts of androgen than men, so a dose that is mild for a man can be virilizing for a woman.

This guide is strictly about dosing: the tiers, why the dose is split, how long cycles run, what bloodwork to check, and — most importantly — the warning signs that mean stop immediately. Some virilization changes, including voice deepening, do not reverse even if you stop promptly. Everything here is educational information, not medical advice, from the team at Oxygen Anabolics.

What the Label Actually Says

The US prescribing information for oxandrolone tablets (DailyMed, National Library of Medicine) sets the daily adult dosage at 2.5 mg to 20 mg, given in 2 to 4 divided doses, with courses of 2 to 4 weeks, repeated intermittently. The same label reports a mean elimination half-life of 10.4 hours in younger volunteers and 13.3 hours in elderly volunteers — the fact behind the split-dosing pattern below. Its warning for women matters most: observe for signs of virilization (deepening of the voice, hirsutism, acne, clitoromegaly), discontinue at the first evidence of mild virilism, and note that some virilizing changes are irreversible even after prompt discontinuation. Oxandrolone is contraindicated in pregnancy. The FDA withdrew approval of Oxandrin in June 2023; in Canada the compound is a Schedule IV controlled substance.

The Female Dosing Tiers

Read the table as a risk ladder, not a menu: each step up adds risk, and no dose carries zero risk.

Tier Daily dose How it is taken Typical length What the evidence says
Assessment / starting 2.5 mg Once daily 2–4 weeks The label’s lowest adult dose; also the maximum dose in the UK Turner trial, where no virilisation was reported.
Common starting dose 5 mg 2.5 mg morning + 2.5 mg evening 4–6 weeks The most commonly discussed starting dose for women.
Experienced dose 10 mg 5 mg morning + 5 mg evening 4–6 weeks Only after a full lower-dose cycle with no warning signs. Above this dose, virilization risk rises sharply.
High-risk zone 15–20 mg Split doses — The label’s upper end. Not a recommended physique dose.

The 2.5 mg anchor comes from the UK Turner syndrome trial: 106 girls randomised to oxandrolone at 0.05 mg/kg/day (maximum 2.5 mg/day) or placebo reported no cases of virilisation, while final height increased by 4.6 cm (95% CI 1.9 to 7.2 cm). Dose is the decisive variable.

Why the Dose Is Split in Two

Oxandrolone’s half-life of about 10.4 hours in younger adults is why female protocols split the daily amount into morning and evening doses: a single daily dose peaks, then falls by roughly half before the next one. Splitting 5 mg into 2.5 mg morning and evening keeps levels steadier — and at 10 mg, 5 mg twice daily about 12 hours apart, rather than 10 mg at once.

Anavar 5 mg tablets for women are the usual unit — one reason 5 mg per day became the standard starting dose: one tablet, split in half across the day. A 2.5 mg dose is half a tablet; 10 mg is two tablets, one morning and one evening. The standard Anavar 20 mg tablets are a men’s unit: one tablet is already double the female ceiling, so women using that format would need to quarter tablets to reach 5 mg. See the full range in our oral steroids category.

Cycle Length and Time Off

The label’s courses run 2 to 4 weeks, repeated intermittently. Female cycles most commonly discussed in training run longer — 4 to 6 weeks — and that extra length is where the liver and lipid costs accumulate. Oxandrolone is a 17-alpha-alkylated oral steroid, and the review of its clinical use (Orr & Fiatarone Singh, 2004) found the most commonly documented adverse effects were transient rises in liver transaminase levels and falls in HDL (“good”) cholesterol — usually reversible after stopping, but dose- and duration-dependent.

The practice most often cited is time off at least as long as time on — six weeks on, six weeks off — with bloodwork before, during, and after: liver enzymes (ALT/AST), a lipid panel with HDL, and a record of your menstrual cycle. That time-off rule is a community practice, not a clinical finding; the evidence supports that transaminase and HDL changes reverse after stopping. See our Anavar for women guide for the general picture.

Weekly planner, alarm clock and gym bag on a bench — the tools for tracking a short, low-dose cycle
Short cycles, split doses and bloodwork keep a female Anavar cycle inside the low-risk zone.

What the Only Study of Women AAS Users Found

Almost everything written about women and steroids is extrapolated from men. One study is the exception: Gruber and Pope (2000) evaluated 75 women athletes in Boston; 25 (33%) reported current or past anabolic-steroid use. Oxandrolone was among the compounds they chose, but the study covered steroid users generally, not oxandrolone alone — so the figures below are context for women’s steroid use as a whole, not oxandrolone-specific rates.

Gruber & Pope (2000): the 25 AAS-using women athletes

Hypomanic symptoms during use

56%

Depressive symptoms on withdrawal

40%

At least one adverse medical effect

76%

Source: Gruber & Pope 2000;69(1):19–26. Share of the 25 women who reported AAS use.

The medical effects those users reported included the virilization signs covered next.

Virilization Warning Signs: Stop Immediately

The label’s instruction is unambiguous: discontinue at the first evidence of mild virilism, because some virilizing changes in women are irreversible even after prompt discontinuation.

Warning sign What it looks like Action
Voice deepening or hoarseness Lower, rougher voice or cracking; often the first sign Stop immediately.
Clitoral enlargement Noticeable growth or sensitivity change Stop immediately.
New or worsening body / facial hair Hirsutism on the face, chest, or back Stop immediately.
Acne New breakouts beyond your normal pattern Stop and reassess.
Menstrual irregularities Missed, delayed, or unusually light or heavy periods Stop and see a doctor.

Record your voice before you start — a 30-second voice note, re-recorded weekly; voice change creeps in gradually, and a recording makes it objective. If any sign appears, stop — do not lower the dose and continue — and tell a doctor exactly what you took and at what dose. For the broader hormone picture, see our guide on whether Anavar suppresses testosterone.

Bloodwork and Monitoring

Before the first tablet, get a baseline: liver enzymes (ALT and AST), a lipid panel (total cholesterol, LDL, HDL, triglycerides), and a note of your menstrual pattern. Mid-cycle, repeat the liver enzymes and lipids — the Orr & Fiatarone Singh review identifies transient transaminase elevations and HDL reductions as the most commonly documented adverse effects. After the cycle, repeat them to confirm they have returned to baseline, and add a blood pressure check.

Common Mistakes Women Make With Anavar Dosing

Halving a male dose. Men’s Anavar doses run 20–80 mg per day; half of that is 10–40 mg, already at or above the female ceiling. Female doses are roughly a tenth of male doses, not a half.

Starting at 10 mg. Ten milligrams is the experienced dose, not the starting dose. Start at 5 mg — or 2.5 mg for the most cautious first cycle.

Extending past 6 weeks. Longer cycles do not add proportional results; they add proportional liver and lipid exposure. The label’s courses are 2–4 weeks for a reason, and 6 weeks is already beyond it.

Ignoring early voice changes. A slightly hoarse voice is not a side effect to monitor — it is the stop signal the label describes, and voice deepening is the virilization sign most likely to be permanent. For what Anavar can and cannot do at these doses, see our five benefits of Anavar guide and our Anavar for men guide.

Frequently Asked Questions

What is a safe starting Anavar dose for a woman?

The most commonly discussed starting dose is 5 mg per day, split into two 2.5 mg doses, for 4 to 6 weeks; the label’s lowest adult dose is 2.5 mg per day. No dose is medically approved for physique or performance use, and “safe” is relative: even 5 mg carries a virilization risk, which is why the first cycle is an assessment.

How long should a woman run Anavar?

Four to six weeks, with at least as much time off afterwards. The label’s medical courses are shorter — 2 to 4 weeks, repeated intermittently — and longer cycles increase liver enzyme and HDL changes. Past 6 weeks, the added risk outweighs any added benefit.

At what dose does virilization start in women?

There is no dose with zero risk and no threshold that guarantees safety. Risk rises sharply above 10 mg per day, and the label instructs women to stop at the first mild sign of virilization — voice deepening or clitoral enlargement — because some changes are irreversible even after prompt discontinuation. In the UK Turner trial, a maximum of 2.5 mg per day produced no virilisation over years of treatment.

Does Anavar affect periods and fertility?

Yes. Menstrual irregularities are listed on the label, and Anavar can suppress natural hormone production: periods may become irregular, light, or stop altogether during a cycle. Oxandrolone is contraindicated in pregnancy because it can masculinize a female fetus, so a pregnancy test before starting and reliable contraception during use are essential.

References

  1. Oxandrolone Tablets, USP — US prescribing information (Upsher-Smith, revised June 2020), via DailyMed, US National Library of Medicine. https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=b4ba1f43-5628-4e79-a4aa-f5c466cb517a&type=display
  2. Orr R, Fiatarone Singh M. The anabolic androgenic steroid oxandrolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs. 2004;64(7):725–750. doi:10.2165/00003495-200464070-00004.
  3. Gruber AJ, Pope HG Jr. Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom. 2000;69(1):19–26. doi:10.1159/000012362. PMID: 10601831.
  4. Gault EJ, Perry RJ, Cole TJ, et al. Effect of oxandrolone and timing of pubertal induction on final height in Turner’s syndrome: randomised, double blind, placebo controlled trial. BMJ. 2011;342:d1980. doi:10.1136/bmj.d1980. PMID: 21493672.

Disclaimer: This article is educational information only and is not medical advice. Anavar (oxandrolone) is a Schedule IV controlled substance in Canada, not approved for physique or performance use, and carries risks including irreversible virilization in women, liver and lipid changes, and hormonal suppression. Consult a qualified healthcare professional before starting, stopping, or changing any medication, and seek prompt medical care for voice changes or any worrying symptom.